BioGaia
114.1 SEK +0.8%2 investors are following this company
BioGaia is a biotechnology company. The company develops, markets and sells probiotic products. The products are mainly based on the bacterium Lactobacillus, which has probiotic effects. Today, the company's products are sold around the global market. Research and development are conducted via the company's external network of research institutions and clinics. The head office is located in Stockholm.
Revenue
1.3B
EBIT %
34.18 %
P/E
31.52
Dividend yield-%
6.05 %
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
BIOG B
Daily low / high price
113.2 / 115
SEK
Market cap
11.52B SEK
Turnover
8.38M SEK
Volume
73K
Latest videos
Financial calendar
General meeting
2024-05-07
Interim report
2024-05-07
Annual dividend
2024-05-08
Bonus dividend
2024-05-08
Interim report
2024-07-07
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
EQT | 11.1 % | 8.3 % |
Fjärde AP-fonden | 7.7 % | 5.8 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Notice to attend the Annual General Meeting of BioGaia AB (publ)
Kallelse till årsstämma i BioGaia AB (publ)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools